• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Private equity continuing to drive health care deals


Increasing interest rates and recession fears have not slowed down the interest in health care from investors

Private equity continues to increase the number of transactions in the health care sector, according to a report from PwC. While megadeals and overall value have been affected by interest rate hikes and fears of a downturn, deal volume has been on the rise thanks to private equity firms interest in health care.

The report also identified payer-provider convergence and investments from nontraditional players helping to drive more value-based care throughout the health care system.

As a result of these factors, plus large levels of corporate and private equity cash, 2023 has a strong outlook for deal volumes in health care.
According to the report, health services deal volumes increased further from levels seen in 2021, but have softened thus far in the fourth quarter this year. Year-over-year deal volumes increased in each quarter through the third quarter, though some pullback has been seen in Q4 through November 15. While deal volumes have continued to increase, deal values have declined from the peak set in 2021, a function of smaller value roll-up and platform add-on transactions representing a greater portion of activity in the current year.

Home health & hospice continues to be a sub-sector driving transaction value in 2022, according to the report. This was one of only two sub-sectors that saw growth in announced deal value from 2021 levels, as pandemic-driven interest in alternative and patient accessible care models continued to be a key theme. There were 114 home health and hospice deals in the 12 months ending November 15, contributing to a 74% increase in deal value from 2021. This growth in deal value was driven by two megadeals – CVS’ acquisition of Signify Health for $8.0B and UnitedHealth / Optum’s acquisition of LHC Group for $6.0B.
Megadeals made up nearly half of deal value over the last 12 months, according to the report. The 12 months ending November 15 had seven megadeals, including:

  • $18 billion merger between two health care real estate investment trusts and an $8.9 billion acquisition of Summit Health-City MD, a provider of primary, specialty and urgent care services, by Village MD (a Walgreens subsidiary). These two deals collectively represent $26.9 billion of the total $44.3 billion of other services deal value in the 12 months ending November 15.
  • Two home health & hospice megadeals, which totaled $14 billion of transaction value.
  • Other megadeals include Quidel Corp.’s acquisition of Ortho Clinical Diagnostics ($8 billion), Mediclinic International’s acquisition by a consortium of investors ($7.4 billion) and Chubb’s acquisition of Cigna's life, accident and supplemental benefits businesses ($5.4 billion).

While merger and acquisition volume was lower when compared to the historic levels of 2021, the health services sector was very active, according to the report.

PwC anticipates increased divestitures activity within health services for 2023 based on a variety of economic, regulatory, and overall strategic repositioning. Given the variety of health care participants (e.g. for profit, not for profit and private equity, etc.), each of the parties have varied processes for decision-making, but growth is the one goal they all share. As management teams assess growth, the power of strategically reviewing and aligning an organization's portfolio is critical to shareholder returns. Other key themes that can help create value through divestitures include: timely decision-making, actively embracing the process of divestitures and navigating inertial factors like entanglements.

Related Videos
Peter H. Reilly, HUB International: ©HUB International
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Claire Ernst, JD, gives expert advice
stock market